Deutsche Bank
CATX icon

Deutsche Bank’s Perspective Therapeutics CATX Stock Holding History

Deutsche Bank’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Buy
100,757
+47,594
+90% +$180K ﹤0.01% 2969
2026
Q1 		$222K Sell
53,163
-1,082
-2% -$4.57K ﹤0.01% 2964
2025
Q4 		$149K Buy
54,245
+3,119
+6% +$8.9K ﹤0.01% 3152
2025
Q3 		$175K Buy
51,126
+7,066
+16% +$25.8K ﹤0.01% 3123
2025
Q2 		$152K Sell
44,060
-948
-2% -$2.5K ﹤0.01% 3089
2025
Q1 		$95.9K Sell
45,008
-1,571
-3% -$4.71K ﹤0.01% 3209
2024
Q4 		$149K Buy
46,579
+20,120
+76% +$164K ﹤0.01% 3183
2024
Q3 		$353K Buy
26,459
+25,511
+2,691% +$339K ﹤0.01% 2646
2024
Q2 		$9.45K Buy
+948
New +$13.7K ﹤0.01% 3462
2020
Q2 		– Sell
-73
Closed – – 4274
2020
Q1 		$0 Sell
73
-697
-91% -$5.26K ﹤0.01% 4378
2019
Q4 		$4K Buy
+770
New +$3.38K ﹤0.01% 4696
2018
Q4 		– Sell
-211
Closed -$1K – 5169
2018
Q3 		$1K Buy
+211
New +$1.18K ﹤0.01% 5273
2014
Q4 		– Sell
-5,000
Closed -$84K – 6157
2014
Q3 		$84K Buy
+5,000
New +$124K ﹤0.01% 4607
2014
Q1 		– Hold
0
– – – 5611
2013
Q4 		– Hold
0
– – – 5419

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Deutsche Bank's CATX Position: Q2 2026 in Review

Deutsche Bank increased its Perspective Therapeutics (CATX) stake by 90% in Q2 2026, buying an estimated $180K and bringing the position to 100,757 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

Deutsche Bank first reported a position in CATX in Q3 2014 and has held it in 13 quarters since. The position peaked at $353K in Q3 2024. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Deutsche Bank held 100,757 shares of Perspective Therapeutics worth $344K as of Q2 2026.
  • Deutsche Bank bought 47,594 Perspective Therapeutics shares in Q2 2026, an estimated $180K.
  • Perspective Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2969 holding.
  • Deutsche Bank first reported a position in Perspective Therapeutics in Q3 2014 and has held it in 13 quarters since.
  • Deutsche Bank's Perspective Therapeutics position peaked at $353K in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.